The National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial
Pharmaceutical companies manufacturing the anti-COVID medicine Remdesivir in India have voluntarily slashed prices following government intervention, National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals announced on Saturday. The authority declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial. After the price cuts, ranging from Rs 1,000 to Rs 2,700, Cadila Healthcare’s Remdac continues to be the cheapest Remdesivir injection at Rs 899.
